Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1356 of 5804
-
Double drug attack on ulcerative colitis shows promise
Disease control Recruiting nowThe main aim of this study is to learn about the effect of treatment with vedolizumab IV (vedolizumab) together with tofacitinib in adults with moderate and severe ulcerative colitis (UC). Another aim is to learn about treatment with Vedolizumab alone after the double treatment. …
Phase: PHASE4 • Sponsor: Takeda • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Could a simple supplement slow ALS? new trial aims to find out
Disease control CompletedGenieUs developed an analysis platform that will be tested to separate study participants with ALS into four categories based on blood work. These general categories are neuroinflammation, oxidative stress, impaired autophagy \& axonal transport, and mitochondrial dysfunction. On…
Phase: PHASE2 • Sponsor: Duke University • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Custom vaccine trains immune system to fight breast cancer
⭐️ VACCINE ⭐️ Recruiting nowThis is a pilot protocol to evaluate the safety, feasibility, and immunogenicity of a personalized breast cancer vaccine based utilizing whole exome sequencing data of a patient's residual breast tumor following neoadjuvant chemotherapy.
Phase: EARLY_PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:02 UTC
-
Free meals and coaching aim to cut pregnancy risks
Prevention OngoingThe goal of this study is to learn whether access to healthy and fresh food, health coaching, and nutrition support intervention can reduce adverse birth outcomes in pregnant women. The main questions it aims to answer are: * Does access to healthy and fresh food, health coachin…
Phase: NA • Sponsor: Medical College of Wisconsin • Aim: Prevention
Last updated Jul 22, 2026 00:00 UTC
-
Alzheimer's vaccine takes first step in human trial
Prevention CompletedThis Phase 1 clinical trial evaluates the safety, tolerability, and immune response of the adjuvanted AV-1959R vaccine in healthy adults aged 40-60. Participants will receive three intramuscular injections of either adjuvanted AV-1959R (100 µg or 300 µg) or adjuvanted placebo at …
Phase: PHASE1 • Sponsor: Nuravax, Inc. • Aim: Prevention
Last updated Jun 27, 2026 09:08 UTC
-
Heart rhythm showdown: ablation may beat defibrillator for some patients
Disease control Recruiting nowEvidence for the usefulness of the defibrillator in cases of preserved left ventricular ejection fraction and well-tolerated ventricular tachycardia (without cardiocirculatory arrest or syncope) is lacking, as no previous trials have included such patients. Additionally, sudden d…
Phase: NA • Sponsor: University Hospital, Toulouse • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Can a Spur-Shaped stent fix Re-Blocked arteries?
Disease control CompletedTo demonstrate acceptable short term safety rates of the Drug-eluting Coronary Spur Stent System as a primary treatment for coronary in-stent restenosis.
Phase: PHASE1 • Sponsor: ReFlow Medical, Inc. • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Can your phone help you quit smoking? new study tests AR app
Symptom relief Recruiting nowThe overall goal of the study is to assess the efficacy of using cue exposure delivered via a smartphone application as an adjunct to Tobacco Quitline treatment to improve smoking abstinence.
Phase: PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Symptom relief
Last updated Jun 27, 2026 09:03 UTC
-
New drug aims to keep leukemia away after transplant
Disease control Recruiting nowThe purpose of this study is to test the safety, effects, and recommended dose of an investigational drug, ziftomenib, in addition to the standard treatment on blood cancer with Allogeneic Hematopoietic Cell Transplantation (allo-HCT). This study plans to learn more about ziftome…
Phase: PHASE1 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New trial aims to ease cancer Patients' breathlessness with tailored oxygen and relaxation techniques
Symptom relief Recruiting nowTo learn about the effect of Structured Personalized Oxygen and Supportive Therapies for Dyspnea in Oncology (SPOT-ON) treatment on the severity of shortness of breath in patients with cancer.
Phase: PHASE2, PHASE3 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
Can brain training apps help veterans with TBI think clearer?
Symptom relief Recruiting nowFor many Veterans, success in achieving goals at work, school and in other aspects of life are top priorities. The abilities to regulate attention, remember key information, and stay calm and on track are fundamental to this success. Unfortunately, Veterans who have experienced a…
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 07:57 UTC
-
New hope for celiac sufferers: drug targets stubborn symptoms despite Gluten-Free diet
Disease control Recruiting nowA study to discover if ZED1227 can improve continued celiac disease symptoms despite a gluten-free diet
Phase: PHASE2 • Sponsor: Dr. Falk Pharma GmbH • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New heart implant aims to prevent strokes without blood thinners
Disease control Recruiting nowAtrial fibrillation (AF) is responsible for 15-20% of ischaemic strokes. These events are often caused by thrombus formation in the left atrium. Thromboembolic risk in AF is primarily prevented by oral anticoagulation. However, this drug-based approach has a number of limitations…
Sponsor: French Cardiology Society • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Sound waves aim to stop hand cramps in musicians and writers
Disease control Recruiting nowThe purpose of this study is to assess the safety and effectiveness of MRI-guided focused ultrasound (MRgFUS) for treating task specific focal hand dystonias (TSFD). TSFD is a type of dystonia that affects hand movements during specific tasks such as writing, playing instruments …
Phase: NA • Sponsor: University of Maryland, Baltimore • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Gut health boost could slow kidney disease, new trial hopes
Disease control Recruiting nowChronic kidney disease (CKD) has become a major public health problem worldwide. Patients with CKD are often accompanied by azotemia due to impaired renal function and excretion of nitrogen metabolic waste, which leads to multiple organ dysfunction, cardiac dysfunction and other …
Phase: PHASE4 • Sponsor: Chujin Cao • Aim: Disease control
Last updated Jun 26, 2026 19:19 UTC
-
Blood test may predict breast cancer return after chemo
Knowledge-focused Recruiting nowThe EXActDNA-003 study will prospectively enroll participants who are planning to undergo chemotherapy for high-risk, early breast cancer, who are willing to provide tissue and blood specimens for circulating tumor DNA (ctDNA) analysis. Participants will be followed for up to 5.…
Sponsor: Exact Sciences Corporation • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC
-
Diabetes drug may also protect bones, early trial hints
Disease control OngoingThe hypothesis for this study is that oral Semaglutide, a GLP-1Ra, has a positive effect on the balance between build-up and degradation as well as the strength of the bones in men and women aged 50-85 years with type 2 diabetes and an increased risk of bone fractures. Treatment …
Phase: PHASE2 • Sponsor: Odense University Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New gel could help heal diabetic foot wounds
Disease control OngoingThe goal of this multi-center, randomized, controlled, evaluator-blinded study is to assess and measure the safety and efficacy of NOX1416 as an adjunct to standard of care (SOC) in the treatment of chronic, non-healing, diabetic foot ulcers (DFUs). Subjects will be randomized to…
Phase: PHASE1 • Sponsor: NOxy Health Products, LLC • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New hope for Hard-to-Treat cancers: experimental drug targets KRAS mutation
Disease control Recruiting nowThis study is a multicentre, open phase I clinical study of dose escalation, dose extension and efficacy extension of HRS-7058 in subjects with advanced malignant tumour. To evaluate the safety, tolerability, pharmacokinetics and efficacy of HRS-7058.
Phase: PHASE1 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New drug aimed at regrowing hair in severe alopecia
Disease control TerminatedThis is a parallel, Phase 2 multinational, multicenter, randomized, double-blind, placebo-controlled, 3-arm study to investigate the efficacy and safety of subcutaneous (SC) injections of amlitelimab treatment as monotherapy in participants aged 18 years and older with severe alo…
Phase: PHASE2 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC